Key market opportunities in the AI clinical trial protocol feasibility tool sector include rising demand for personalized and ...
How AI, robotics, and precision medicine are transforming cancer care—bridging hope, technology, and humanity in the ongoing ...
Countable Labs, the developer of Countable PCR, the leading PCR innovation transforming how science measures biology, announced the launch of the RNA Module for Countable PCR. This new solution brings ...
Watchmaker Genomics today announced the launch of TAPS+, a next-generation technology that unites genetic and epigenetic readouts from the same DNA molecule. By capturing multiple biological ...
Although heart cells and skin cells contain identical instructions for creating proteins encoded in their DNA, they're able ...
IEEE Spectrum on MSN
Inside the Massive Effort to Sequence All of Europe’s Lepidoptera
It’s a little after 6:30 on a brisk July morning in a stone hut high in the Italian Alps. A gently hissing wood fire is ...
Parkinson’s disease (PD) remains one of the most challenging neurodegenerative disorders to diagnose and monitor.
The acquisition, which enables Qiagen to enter the single-cell sequencing market, is expected to close in December and contribute $40 million to 2026 revenues.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback